Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity.
Ursula S SandauMariana Colino-OliveiraAbbie JonesBounmy SaleumvongShayla Q CoffmanLong LiuCatarina Miranda-LourençoCátia PalminhaVânia L BatalhaYiming XuYuqing HuoMaria José DiógenesAna M SebastiãoDetlev BoisonPublished in: The Journal of neuroscience : the official journal of the Society for Neuroscience (2017)
A novel human genetic condition (OMIM #614300) that is based on mutations in the adenosine kinase (Adk) gene has been discovered recently. Affected patients develop hepatic encephalopathy, seizures, and severe cognitive impairment. To model and understand the neurological phenotype of the human mutation, we generated a new conditional knock-out mouse with a brain-specific deletion of Adk (AdkΔbrain). Similar to ADK-deficient patients, AdkΔbrain mice develop seizures and cognitive deficits. We identified increased basal synaptic transmission and enhanced adenosine A2A receptor (A2AR)-dependent synaptic plasticity as the underlying mechanisms that govern these phenotypes. Our data show that neurological phenotypes in ADK-deficient patients are intrinsic to ADK deficiency in the brain and that blocking A2AR activity therapeutically can attenuate neurological symptoms in ADK deficiency.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- resting state
- white matter
- endothelial cells
- peritoneal dialysis
- prognostic factors
- cognitive impairment
- protein kinase
- functional connectivity
- adipose tissue
- multiple sclerosis
- genome wide
- physical activity
- patient reported
- subarachnoid hemorrhage
- copy number
- depressive symptoms
- dna methylation
- brain injury
- patient reported outcomes
- transcription factor
- blood brain barrier
- replacement therapy